Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongming Chen

Showing results (171-180 of 175) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 175 results.
Journal of Cheminformatics|January 12, 2021
Industry-scale application and evaluation of deep learning for drug target predictionNoé Sturm, Andreas Mayr, Thanh Le Van, et al.
Nature Communications|November 23, 2024
Discovery of orally bioavailable SARS-CoV-2 papain-like protease inhibitor as a potential treatment for COVID-19Yongzhi Lu, Qi Yang, Ting Ran, et al.
Nature Communications|January 21, 2025
Author Correction: Discovery of orally bioavailable SARS-CoV-2 papain-like protease inhibitor as a potential treatment for COVID-19Yongzhi Lu, Qi Yang, Ting Ran, et al.
Journal of Medicinal Chemistry|June 6, 2020
Fragment-based Differential Targeting of PPI Stabilizer InterfacesXavier Guillory, Madita Wolter, Seppe Leysen, et al.
Nature Cell Biology|November 6, 2024
NAT10-mediated mRNA N<sup>4</sup>-acetylcytidine reprograms serine metabolism to drive leukaemogenesis and stemness in acute myeloid leukaemiaSubo Zhang, Feng Huang, Yushuai Wang, et al.
Pageof 18

Showing results (171-180 of 175) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 175 results.
Journal of Cheminformatics|January 12, 2021
Industry-scale application and evaluation of deep learning for drug target predictionNoé Sturm, Andreas Mayr, Thanh Le Van, et al.
Nature Communications|November 23, 2024
Discovery of orally bioavailable SARS-CoV-2 papain-like protease inhibitor as a potential treatment for COVID-19Yongzhi Lu, Qi Yang, Ting Ran, et al.
Nature Communications|January 21, 2025
Author Correction: Discovery of orally bioavailable SARS-CoV-2 papain-like protease inhibitor as a potential treatment for COVID-19Yongzhi Lu, Qi Yang, Ting Ran, et al.
Journal of Medicinal Chemistry|June 6, 2020
Fragment-based Differential Targeting of PPI Stabilizer InterfacesXavier Guillory, Madita Wolter, Seppe Leysen, et al.
Nature Cell Biology|November 6, 2024
NAT10-mediated mRNA N<sup>4</sup>-acetylcytidine reprograms serine metabolism to drive leukaemogenesis and stemness in acute myeloid leukaemiaSubo Zhang, Feng Huang, Yushuai Wang, et al.
Pageof 18